During the period from 2004 to 2015, Sino-Us Huadong achieved substantial development through four three-year plans. In the fourth three-year plan (2013-2015), the company worked together. Following the idea of "be unique or first" put forward by chairman Li Bangliang, we optimized the product structure, ensured the supply of production capacity and inspired the organizational leadership through strong strategic foresight and decision-making such as organizational structure reform and product structure adjustment.

The integration of industrialization and informationization. The 16th CPC national congress, 17th CPC national congress and 18th CPC national congress all proposed and promoted the development path of integration of the two systems. On May 8, 2015, the state council formally issued the first 10-year action program made in China 2025 for the implementation of the strategy of "manufacturing power" in China that made clear the strategic goal “ by 2025, the integration of industrialization and informatization will reach a new level.”

This month, the studio office of the joint stock company industrial film will be successfully concluded, and the site office of the commercial film will be held next month. Company industrial film held a total of 10 on-site office meetings, the company's chairman Li Bbangliang led the company's leadership and related functional department leaders all attended.

Huadong Health Child Shop received the title of “ Hangzhou five-star tourist goods outlets” and “ Hangzhou gift - tourism commodity standardization store”. Huadong Health Stadium Shop received the title of “ Hangzhou four-star tourist goods outlets”.

“ The success of doxycycline is a major weapon in our new drug development strategy.” The company head said, “ The new drug took seven years to fill the gap in China.”

On Sep.28, the company officially started the 2016 budget preparation according to the requirement of broad group, which is expected to continue until January.

Sino-US 2015 fourth quarter marketing work conference was held During Oct.19 to 20.

“ The 2015 China A-share listed company value ranking was released on Cct 16, 2015.” After being listed as "top 10 listed pharmaceutical and medical companies in the first China listed company value ranking list" last year, Huadong Medicine has been awarded the "top 10 listed pharmaceutical and medical companies in the second China listed company value ranking list" award this year.

Recently, China securities news unveiled the golden cow award for the 17th (2014) listed company, and east China pharmaceutical was the big winner, winning three awards, including 2014 top 100 listed companies of Jinniu, 2014 annual golden bull youth company and 2014 annual best company secretary.

In order to further accelerate personnel training at all levels, promote the construction of the company's training system, so that talent development and staff training work can better support the realization of the company's strategy and business goals, the human resources department of the company started the "dandelion plan" at the beginning of this year, focusing on the training team for the establishment of the company.

Recently, the company's capsules, tablets, granules, raw materials (the fermentation cordyceps sinensis powder) and raw materials (tacrolimus), and other products successfully passed the new GMP inspection.

Fortune China has released a list of the top 500 companies in China in 2015. Huadong Medicine Co.,Ltd., was again listed as the 268th place with solid growth operating performance, with 18.947 billion yuan of operating revenue.